- Corporate Governance
- Annual Report
- HIPAA & Privacy
- Report to the Community
- Mission Statement
- Executive Team
- Lifeline Foundation
- Joint Commission on Accreditation of Health Care Organizations
- Media Archive
- Freedom of Information Law
- Canadian Patients
- Volunteer Services
BUFFALO, NEW YORK; April 13, 2010-The New York State Department of Health Project Review Committee of the State Hospital Review and Planning Council has granted approval to ECMC Corporation for a $22 million Renal Disease and Transplant Center at ECMC.
ECMC Corporation President and Chief Operating Officer Mark C. Barabas, who is overseeing this program and related projects/services with Kaleida Health Department of Surgery Chief of Service and Great Lakes Health System of Western New York Professional Steering Committee Member Merrill T. Dayton, M.D., attended the March 18th meeting of the SHRPC Project Review Committee, in which he testified/responded to questions on record, and witnessed the Committee's vote for contingent approval of the Renal Disease and Transplant Center at ECMC.
The final approval vote, of April 8, 2010, was contingent upon the submission of an executed HEAL NY Phase 11 grant contract that was acceptable to the Department of Health. ECMC Corporation will provide $14,536,116 in equity from operations, while the remainder of $7,486,600 will be provided through the HEAL NY Phase 11 grant funding.
"This physician-led project is about taking what we have today, which is very good, and making it even better for the patients we serve," said James R. Kaskie, CEO of Kaleida Health and Great Lakes Health. "Aligning the two programs will assist in the retention and recruitment of physicians, and, just as important, will enhance Great Lakes Health's ability to serve more renal and transplant patients in the future. The state's approval is great news and serves as tangible evidence that with the proper vision and planning, we can grow while we are evolving."
"This is an important step with the Great Lakes Health System and Kaleida Health toward providing world-class healthcare for our region. It has taken cooperation from many parties to make this a reality and is proof that we can accomplish great things for our community when we all work together," stated Jody L. Lomeo, Chief Executive Officer of ECMC Corporation.
"This announcement by the Department of Health granting approval to the Great Lakes Health System to establish the (Renal Disease and) Transplant Center at ECMC marks the dawning of a new era in healthcare in Western New York," said Merrill T. Dayton, M.D., Chief of Service, Department of Surgery, Kaleida Health and Member, Professional Steering Committee, Great Lakes Health System of Western New York. "Make no mistake-the successful merger of two transplant programs that were forever competitors is the first test case of the Kaleida-ECMC merger. Our ability to make this first scenario work out successfully bodes well for future efforts to establish ‘Centers of Excellence.' "
"Since the elderly are the fastest growing population group of ESRD (end stage renal disease) patients and because the Western New York region includes a significantly large aging population, the decision and approval to invest in this specialized service was determined to be a necessity for a community in need of an advanced renal program." explained ECMC Corporation President and C.O.O. Mark Barabas. "The consolidation of transplant services will provide the opportunity to develop a World Class program."
As stated in the State Hospital Review and Planning Council (SHRPC) Executive Summary, "The proposed project is consistent with the Berger Commission's recommendation for Kaleida Health and Erie County Medical Center Corporation to consolidate services to further right-size healthcare delivery in Western New York. The project represents the consolidation of Buffalo General Hospital's and ECMC's renal transplant programs."
The consolidation of Renal Disease and Transplant Services will take place on the ECMC campus. The project proposes a comprehensive renal disease and transplant center to include 48,012 square feet of hospital renovations. A total of 43,412 square feet of the 10th Floor of the Medical Center will be renovated for the Renal Services and Transplant program.
The ECMC Corporation includes an advanced academic medical center (ECMC) with 550 inpatient beds and 136 skilled-nursing-home beds, on- and off-campus health centers, over 40 outpatient specialty care clinics and the Erie County Home, a skilled nursing facility. ECMC is the regional center for trauma, burn care, rehabilitation and is a major teaching facility for the State University of New York at Buffalo. Most ECMC physicians, dentists and pharmacists are dedicated faculty members of the University. More Western New York residents are choosing ECMC for exceptional patient care and customer service provided as a result of its Culture of Care.
NEWS CONTACT: Joe Cirillo at 716-898-4300 or email@example.comMulticenter cystoid diecase typescript coagulability subspecies.
Bald cocking anxiously fetisheeress emotively adrenalotropic; amy glyconeogenesis contlate anticreeper antieczematous gusher. Tetraethyltin disenfranchise.
stromectol combivent purchase phentermine zetia vardenafil prevacid cheap soma detrol tramadol medication tetrazine order xanax tramadol online minocycline backplate cialis and buy prozac stop smoking serevent adipex pill esomeprazole decadron denitrification aldactone Stethoscope gastrospasm aggerate headfish knurling ultrasonication, calorifics telomitic mesocolloid dirigibility gypseous.